TF4

DICHLORO-ACETIC ACID

Created: 2005-06-08
Last modified:  2011-06-04

Help

Find related ligands:

Chemical Details

Formal Charge0
Atom Count8
Chiral Atom Count0
Bond Count7
Aromatic Bond Count0
2D diagram of TF4
Toggle HydrogenToggle Labels

Chemical Component Summary

NameDICHLORO-ACETIC ACID
Systematic Name (OpenEye OEToolkits)2,2-dichloroethanoic acid
FormulaC2 H2 Cl2 O2
Molecular Weight128.942
TypeNON-POLYMER

Chemical Descriptors

TypeProgram Version Descriptor
SMILESACDLabs10.04ClC(Cl)C(=O)O
SMILESCACTVS3.341OC(=O)C(Cl)Cl
SMILESOpenEye OEToolkits1.5.0C(C(=O)O)(Cl)Cl
Canonical SMILESCACTVS3.341 OC(=O)C(Cl)Cl
Canonical SMILESOpenEye OEToolkits1.5.0 C(C(=O)O)(Cl)Cl
InChIInChI1.03 InChI=1S/C2H2Cl2O2/c3-1(4)2(5)6/h1H,(H,5,6)
InChIKeyInChI1.03 JXTHNDFMNIQAHM-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank IDDB08809 
NameDichloroacetic acid
Groups
  • approved
  • investigational
DescriptionDichloroacetic acid, often abbreviated DCA, is an acid analogue of acetic acid in which two of the three hydrogen atoms of the methyl group have been replaced by chlorine atoms. Salts of DCA are used as drugs since they inhibit the enzyme pyruvate dehydrogenase kinase. Early reports of its activity against brain cancer cells led patients to treat themselves with DCA, which is commercially available in non-pharmaceutical grade. A phase 1 study in 5 patients concluded that DCA was safe, but wasn't designed to establish effectiveness. DCA was approved for use in Canada in 1989 (as a topical formulation for treatment of warts and for cauterization and removal of a wide variety of skin and tissue lesions), but was cancelled post market.
Synonyms
  • Sodium dichloroacetate
  • Dichloroacetic acid
  • Dichloracetic acid
  • DCA
  • Dichloroacetate
Brand NamesBichloracetic Acid 100%
Categories
  • Acetates
  • Acids, Acyclic
  • Chloroacetates
  • Hydrocarbons, Chlorinated
  • Hydrocarbons, Halogenated
CAS number79-43-6

Drug Targets

NameTarget SequencePharmacological ActionActions
[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1, mitochondrialMRLARLLRGAALAGPGPGLRAAGFSRSFSSDSGSSPASERGVPGQVDFYA...unknowninhibitor
Maleylacetoacetate isomeraseMQAGKPILYSYFRSSCSWRVRIALALKGIDYKTVPINLIKDRGQQFSKDF...unknown
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem 6597
ChEMBL CHEMBL13960
ChEBI CHEBI:36386
CCDC/CSD YIQGAH02, YIQGAH03, KHDCAC12, BIZYOA, VAHYEL, KHDCAC11, GEPFIR, POLLOU, MUSQUP, YIQGAH01, KHDCAC10, KHDCAC, BIZYOA01
COD 2102961, 2102962, 2102960, 2102959